Fig. 4From: High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroidsLog-transformed 24–hour serum cortisol ratio (a) and Cmin serum cortisol ratio (b) to baseline for end of treatment periodBack to article page